Not Yet RecruitingNot Applicable

Individual Risk Profiles for Adverse Drug Reactions in Geriatric Patients

2,000 participantsStarted 2022-07

Plain-language summary

This project will generate a prospective cohort of geriatric patients with polypharmacy which will be characterized for vulnerability profiles of adverse drug reactions.

Who can participate

Age range70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 70 years or older * Current drug therapy with three or more drugs * Being a patient in the interdisciplinary polypharmacy consultation service of the geriatric university outpatient clinic * Sufficient mobility (minimum: Wheelchair mobility) * Written informed consent of the patient or the legal representative Exclusion Criteria: * No sufficient communication possible * Patients classified as terminally ill by the medical staff * Patients, that are incapable to give their informed consent and who do not have a legal representative

What they're measuring

Identification of vulnerability profiles of adverse drug reactions

Timeframe: February 2022 - February 2032

Trial details

NCT IDNCT05247814

SponsorRWTH Aachen University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2032-02

Contact for this trial

Mathias Freitag

+492417501116 mfreitag@ukaachen.de

View on ClinicalTrials.gov More Polypharmacy trials